Editorial:Frontiers in research on the Maillard reaction in aging and chronic disease

Clinical Chemistry and Laboratory Medicine

Volumn 52, Issue 1, 2014, Pages 1-3

  Baynes, John W ^a   Gillery, P ^b,c  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b AMERICAN MEMORIAL HOSPITAL   (France)

^c UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINO ACID;

AGING; BLOOD VESSEL WALL; CARDIOVASCULAR DISEASE; CHEMICAL MODIFICATION; CHRONIC DISEASE; EDITORIAL; GLYCATION; HUMAN; MEDICAL RESEARCH; NITROSATIVE STRESS; OXIDATIVE STRESS; PRIORITY JOURNAL; BLOOD; LIPID PEROXIDATION; RESEARCH;

AGING; CHRONIC DISEASE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LIPID PEROXIDATION; MAILLARD REACTION; OXIDATIVE STRESS; RESEARCH;

EID: 84891454244     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2013-0551     Document Type: Editorial

References (23)

1. Maillard LC. Action des acides amines sur les sucres: formation des melanoidiones par voie methodique. Compt Rend 1912;154:66-8.
2. Robert L, Labat-Robert J. Role of the Maillard reaction in aging and age-related diseases. Studies at the cellular-molecular level. Clin Chem Lab Med 2014;52:5-10.
3. Gillery P, Jaisson S. Post-translational modification derived products (PTMDPs): toxins in chronic diseases? Clin Chem Lab Med 2014;52:11-6.
4. Monnier VM, Sun W, Sell DR, Fan X, Nemet I, Genuth S. Glucosepane: A poorly understood advanced glycation end product of growing importance for diabetes and its complications. Clin Chem Lab Med 2014;52:27-38.
5. Arsov S, Graaff R, van Oeveren W, Stegmayr B, Sikole A, Rakhorst G, et al. Advanced glycation end-products and skin autofluorescence in end-stage renal disease: A review. Clin Chem Lab Med 2014;52:17-26.
6. Frizzell F, Baynes JW. Chelation therapy for management of diabetic complications: A hypothesis and a proposal for clinical laboratory assessment of metal ion homeostasis in plasma. Clin Chem Lab Med 2014;52:69-75.
7. Voziyan P, Brown KL, Chetyrkin S, Hudson B. Site-specific AGE modifications in the extracellular matrix: A role for glyoxal in protein damage in diabetes. Clin Chem Lab Med 2014;52:39-45.
8. Suzuki K, Nakagawa K, Miyazawa T. Augmentation of blood lipid glycation and lipid oxidation in diabetic patients. Clin Chem Lab Med 2014;52:47-52.
9. Delgado-Andrade C. Maillard reaction products: some considerations on their health effects. Clin Chem Lab Med 2014;52:53-60.
10. Toda M, Heilmann M, Ilchmann A, Vieths S. The Maillard reaction and food allergies: is there a link? Clin Chem Lab Med 2014;52:61-7.
11. Scheijen JL, Schalkwijk CG. Quantification of glyoxal, methylglyoxal and 3-deoxyglucosone in blood and plasma by ultra performance liquid chromatography tandem mass spectrometry; evaluation of blood specimen. Clin Chem Lab Med 2014;52:85-91.
12. Hellwig A, Scherber A, Koehler C, Hanefeld M, Thomas Henle. A new HPLC-based assay for the measurement of fructosamine-3-kinase (FN3K) and FN3K-related protein activity in human erythrocytes. Clin Chem Lab Med 2014;52:93-101.
13. Tanhäuserová V, Kuricová K, Pácal L, Bartáková V, ehová J, Svojanovský J, et al. Genetic variability in enzymes of metabolic pathways conferring protection against non-enzymatic glycation vs. diabetes-related morbidity and mortality. Clin Chem Lab Med 2014;52:77-83.
14. Schulman CI, Uribarri J, Cai W, Manning R, Landy DC, Gallardo M, Castillo A, Namias N, Livingstone A, Striker GE, Vlassara H. Increased circulating advanced glycation endproducts (AGEs) in acute trauma patients. Clin Chem Lab Med 2014;52:103-8.
15. Menini T, Ikeda H, Kimura S, Gugliucci A. Circulating soluble RAGE increase after a cerebrovascular event. Clin Chem Lab Med 2014;52:109-16.
16. Monacelli F, Borghi R, Pacini D, Serrati C, Traverso N, Patrizio Odetti. Pentosidine determination in CSF: A potential biomarker of Alzheimer'disease? Clin Chem Lab Med 2014;52:117-20.
17. Tiessen AH, Jager W, ter Bogt NC, Beltman FW, van der Meer K, Broer J, et al. Skin autofluorescence as proxy of tissue AGE accumulation is dissociated from SCORE cardiovascular risk score, and remains so after 3 years. Clin Chem Lab Med 2014;52:121-7.
18. Sourris KC, Lyons JG, Dougherty SL, Chand V, Straznicky NE, Schlaich MP, et al. Plasma advanced glycation end products (AGEs) and NF-B activity are independent determinants of diastolic and pulse pressure. Clin Chem Lab Med 2014;52:129-38.
19. Šebeková K, Krivošíková Z, Gajdoš M. Total plasma N-(carboxymethyl)lysine and sRAGE levels are inversely associated with number of metabolic syndrome risk factors in non-diabetic young-to-middle-aged medication-free subjects. Clin Chem Lab Med 2014;52:139-49.
20. Adamopoulos C, Farmaki E, Spilioti E, Kiaris H, Piperi C, Papavassiliou AG. Advanced glycation end-products induce endoplasmic reticulum stress in human aortic endothelial cells. Clin Chem Lab Med 2014;52:151-60.
21. Kosmachevskaya OV, Shumaev KB, Nasybullina EI, Topunov AF. Formation of Nitri-and Nitrosylhemoglobin in Systems modeling the Maillard reaction. Clin Chem Lab Med 2014;52:161-8.
22. Pageon H, Zucchi H, Rousset F, Monnier VM, Asselineau D. Skin aging by glycation: lessons from the reconstructed skin model. Clin Chem Lab Med 2014;52:169-74.
23. Danoux L, Mine S, Abdul-Malak N, Henry F, Jeanmaire C, Freis O, et al. How to help skin to cope with glycoxidation? Clin Chem Lab Med 2014;52:175-82.